We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OSE Immunotherapeutics | TG:6OP | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
0.19 | 2.18% | 8.90 | 0.00 | 22:50:06 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
8.86 | 8.94 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | 0 | 8.90 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
04/11/2024 | 17:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Announces Statistically Significant and Clinically.. |
04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Annonce des Résultats Cliniquement Probants et.. |
17/10/2024 | 16:00 | UKREG | OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology.. |
17/10/2024 | 16:00 | UKREG | OSE Immunotherapeutics présente une nouvelle technologie bispécifique de.. |
02/10/2024 | 16:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
26/9/2024 | 16:00 | UKREG | OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides.. |
26/9/2024 | 16:00 | UKREG | OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables.. |
10/9/2024 | 05:30 | UKREG | OSE Immunotherapeutics Announces Global Launch of Artemia Phase 3.. |
10/9/2024 | 05:30 | UKREG | OSE Immunotherapeutics annonce le lancement international d’Artemia,.. |
OSE Immunotherapeutics (6OP) Share Charts1 Year OSE Immunotherapeutics Chart |
|
1 Month OSE Immunotherapeutics Chart |
Intraday OSE Immunotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions